Sopharma AD financials at a glance

+ Portfolio

The revenue of Sopharma AD is reported as 1.87442 billion Leva in the fiscal year 2023. The earnings were 0 Leva per share in 2023, which was 226.09 higher than 2020. And about -0.02439 billion Leva are reported as free cash flow in the financials of Sopharma AD 2023. Dividends of 0.9 Leva per share were paid to shareholders of Sopharma AD stock BUL:SFA in fiscal 2023.

лв1.66B

Revenue

лв0.75

Earnings Per Share

21.64%

Gross Margin %

лв90.52M

Free Cash Flow

Revenue

1,662.99

Earnings Per Share

0.75

Gross Margin %

21.64

Free Cash Flow

90.52

Financials

Year	Year	TTM	2022	2020	2015	2012	2011	2010	2009
Rev.	Revenue	N/A	лв1.66B	лв1.44B	лв0.00M	лв0.00M	лв645.34M	лв600.33M	лв204.50M
GM %	Gross Margin %	21.73%	21.64%	21.46%	25.36%	28.73%	29.98%	31.70%	32.74%
OM	Operating Margin	5.51%	5.14%	3.26%	5.43%	7.35%	7.75%	9.77%	10.31%
EPS	Earnings Per Share	лв0.62	лв0.75	лв0.23	лв0.17	лв0.19	лв0.30	лв0.32	лв0.21
Div.	Dividends	N/A	лв0.00	лв0.04	лв0.00	лв0.00	лв0.00	лв0.00	лв0.00
PR %	Payout Ratio %	0	0.00%	17.39%	0	0	0	0.00%	0.00%
Sha.	Shares	N/AM	121.32M	125.79M	129.32M	128.15M	129.07M	130.82M	132M
OCF	Operating Cash Flow	N/A	лв109.60M	лв-,179.23M	лв0.00M	лв0.00M	лв48.89M	лв70.77M	лв0.00M
FCF	Free Cash Flow	N/A	лв90.52M	лв-,202.62M	лв49.52M	лв0.00M	лв9.66M	лв55.05M	лв0.00M
FCFS	Free Cash Flow Per Share	лв-0.25	лв0.71	лв-1.64	лв0.35	лв-0.45	лв0.09	лв0.41	лв0.19

Sopharma AD financials at a glance

Financials

Discover